Homoharringtonine Supplier - China Wholesale & OEM Exporter

Homoharringtonine (HHT) is a natural product derived from the bark of the Cephalotaxus tree. It has been found to have anti-tumor effects and is used as a therapeutic agent in the treatment of leukemia.

HHT works by inhibiting the growth and proliferation of cancer cells. It does this by targeting the ribosome, a cellular structure responsible for protein synthesis. By binding to the ribosome, HHT interferes with the process of making proteins necessary for the survival and multiplication of cancer cells.

HHT has shown promising results in clinical trials for the treatment of chronic myeloid leukemia (CML) and acute myeloid leukemia (AML). In fact, it has been approved for the treatment of CML in China, and has been used to treat over 300,000 patients.

HHT is often used in combination with other chemotherapy drugs to increase its effectiveness. It can also be administered orally or intravenously.

Despite its effectiveness, HHT can have side effects, such as gastrointestinal disturbance, bone marrow suppression, and liver function damage. Therefore, patients need to be carefully monitored during treatment.

In conclusion, Homoharringtonine has proven to be a valuable tool in the fight against leukemia. Its ability to inhibit the growth of cancer cells through its ribosome-targeting mechanism makes it an effective therapeutic agent. Ongoing research may reveal new ways to harness its potential and expand its use in the treatment of other cancers.